Cargando…
A T cell-targeted multi-antigen vaccine generates robust cellular and humoral immunity against SARS-CoV-2 infection
SARS-CoV-2, the etiological agent behind the coronavirus disease 2019 (COVID-19) pandemic, has continued to mutate and create new variants with increased resistance against the WHO-approved spike-based vaccines. With a significant portion of the worldwide population still unvaccinated and with wanin...
Autores principales: | Boulton, Stephen, Poutou, Joanna, Gill, Rida, Alluqmani, Nouf, He, Xiaohong, Singaravelu, Ragunath, Crupi, Mathieu J.F., Petryk, Julia, Austin, Bradley, Angka, Leonard, Taha, Zaid, Teo, Iris, Singh, Siddarth, Jamil, Rameen, Marius, Ricardo, Martin, Nikolas, Jamieson, Taylor, Azad, Taha, Diallo, Jean-Simon, Ilkow, Carolina S., Bell, John C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10562195/ https://www.ncbi.nlm.nih.gov/pubmed/37822719 http://dx.doi.org/10.1016/j.omtm.2023.101110 |
Ejemplares similares
-
Nanoluciferase complementation-based bioreporter reveals the importance of N-linked glycosylation of SARS-CoV-2 S for viral entry
por: Azad, Taha, et al.
Publicado: (2021) -
Implications for SARS-CoV-2 Vaccine Design: Fusion of Spike Glycoprotein Transmembrane Domain to Receptor-Binding Domain Induces Trimerization
por: Azad, Taha, et al.
Publicado: (2020) -
Single-dose replicating poxvirus vector-based RBD vaccine drives robust humoral and T cell immune response against SARS-CoV-2 infection
por: Boulton, Stephen, et al.
Publicado: (2022) -
SARS-CoV-2 S1 NanoBiT: A nanoluciferase complementation-based biosensor to rapidly probe SARS-CoV-2 receptor recognition
por: Azad, Taha, et al.
Publicado: (2021) -
A High-Throughput NanoBiT-Based Serological Assay Detects SARS-CoV-2 Seroconversion
por: Azad, Taha, et al.
Publicado: (2021)